(Q58854574)

English

A combination of interleukin-2 and 60 nm cationic supramolecular biovectors for the treatment of established tumours by subcutaneous or intranasal administration

scientific article published on 01 May 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11334732%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

A combination of interleukin-2 and 60 nm cationic supramolecular biovectors for the treatment of established tumours by subcutaneous or intranasal administration (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11334732%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

0 references

Didier Betbeder

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11334732%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

author name string

S El mir

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11334732%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

A Casanova

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11334732%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

F Triebel

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11334732%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

publication date

1 May 2001

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11334732%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

European Journal of Cancer

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11334732%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

37

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11334732%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11334732%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1053-1060

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11334732%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Rational immunotherapy with interleukin 2

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900084-3

7 January 2021

based on heuristic

inferred from DOI database lookup

NIH conference. New approaches to the immunotherapy of cancer using interleukin-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900084-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900084-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Cancer vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900084-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900084-3

7 January 2021

based on heuristic

inferred from DOI database lookup

T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900084-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of antigen-specific T cell anergy: An early event in the course of tumor progression

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900084-3

7 January 2021

based on heuristic

inferred from DOI database lookup

CTLA-4 blockade reverses CD8+ T cell tolerance to tumor by a CD4+ T cell- and IL-2-dependent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900084-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Stabilization and enhancement of interleukin-2 in vitro bioactivity by new carriers: supramolecular biovectors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900084-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterisation and phase behaviour of phospholipid bilayers adsorbed on spherical polysaccharidic nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900084-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination of human cytomegalovirus recombinant immediate-early protein (IE1) with 80 nm cationic biovectors: protection from proteolysis and potentiation of presentation to CD4+ T-cell clones in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900084-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Functional consequences of interleukin 2 receptor expression on resting human lymphocytes. Identification of a novel natural killer cell subset with high affinity receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900084-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Inducing autoimmune disease to treat cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900084-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-dose IL-2 treatment: Activation of discrete T- and NK-cell sub-populationsin vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900084-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Clonal T cell expansion induced by interleukin 2 therapy in blood and tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900084-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Vaccination with a recombinant vaccinia virus encoding a "self" antigen induces autoimmune vitiligo and tumor cell destruction in mice: requirement for CD4(+) T lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900084-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of a secretory IgA response in the murine female urogenital tract by immunization of the lungs with liposome-supplemented viral subunit antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900084-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunotherapy of a mouse mammary carcinoma by sustained peritumor release of IL-2

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900084-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Paracrine cytokine adjuvants in cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900084-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytokine depot formulations as adjuvants for tumor vaccines. I. Liposome-encapsulated IL-2 as a depot formulation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900084-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0959-8049(01)00084-3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11334732%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11334732%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q58854574&oldid=2098790019"